摘要
目的:本研究旨在验证 miR-30e-5p 是否靶向自噬的关键调节因子 Beclin1 (BECN1),并探讨 miR-30e-5p 和 Beclin1 通过介导自噬和细胞凋亡在造影剂诱导的急性肾损伤中的作用。西亚基)。 方法:人肾小管上皮HK-2细胞用Urografin处理构建CI-AKI细胞模型。实时逆转录聚合酶链反应用于检测基因表达。双荧光素酶报告测定和内源性验证用于验证靶向和调节功能。 Western blot检测蛋白表达。使用甲基噻唑基二苯基-溴化四唑(MTT)测定法检测细胞增殖。使用末端脱氧核苷酸转移酶介导的缺口末端标记法检测细胞凋亡,并使用透射电子显微镜检测自噬。 结果: 暴露于 Urografin 2 小时的 HK-2 细胞诱导 miR-30e-5p 显着增加。 miR-30e-5p 对 Beclin1 具有靶向作用。此外,Urografin 暴露可通过增加半胱天冬酶 3 基因表达和抑制自噬来增强细胞凋亡,自噬是由 miR-30e-5p 调节的 Beclin1 表达降低诱导的,从而导致肾细胞损伤。 miR-30e-5p 的下调或 Beclin1 的上调通过促进自噬和抑制 Urografin 处理的细胞中的细胞凋亡来恢复细胞活力。 结论 : Urografin 增加 HK-2 细胞 miR-30e-5p 的表达, 从而降低 Beclin1 水平, 抑制自噬, 但诱导细胞凋亡, 这可能是 CI-AKI 的机制。
关键词: 急性肾损伤,对比,miR-30e-5p,自噬,细胞凋亡,HK-2 细胞。
Current Medicinal Chemistry
Title:miR-30e-5p Regulates Autophagy and Apoptosis by Targeting Beclin1 Involved in Contrast-induced Acute Kidney Injury
Volume: 28 Issue: 38
关键词: 急性肾损伤,对比,miR-30e-5p,自噬,细胞凋亡,HK-2 细胞。
摘要:
Aims: This study aims to verify if miR-30e-5p targets Beclin1 (BECN1), a key regulator of autophagy, and investigate the function of miR-30e-5p and Beclin1 through mediating autophagy and apoptosis in contrast-induced acute kidney injury (CIAKI).
Methods: Human renal tubular epithelial HK-2 cells were treated with Urografin to construct a cell model of CI-AKI. Real-time reverse transcription-polymerase chain reaction was used to detect gene expression. The dual-luciferase reporting assay and endogenous validation were used to verify targeting and regulating function. The expressions of protein were detected using Western blot. Cell proliferation was detected using methylthiazolyldiphenyl- tetrazolium bromide (MTT) assay. Cell apoptosis was detected using terminal- deoxynucleoitidyl transferase mediated nick end labeling assay, and autophagy was detected using transmission electron microscopy.
Results: HK-2 cells exposed to Urografin for 2 h induced a significant increase in miR-30e-5p. miR-30e-5p had a targeting effect on Beclin1. Moreover, Urografin exposure can enhance cell apoptosis by increasing caspase 3 gene expression and inhibiting autophagy, which was induced by decreased Beclin1 expression regulated by miR-30e-5p, thereby resulting in renal cell injury. Downregulation of miR-30e-5p or upregulation of Beclin1 restored cell vitality by promoting autophagy and suppressing apoptosis in Urografin-treated cells.
Conclusion : Urografin increased the expression of miR-30e-5p in HK-2 cells and thus decreased Beclin1 levels to inhibit autophagy, but induced apoptosis, which may be the mechanism for CI-AKI.
Export Options
About this article
Cite this article as:
miR-30e-5p Regulates Autophagy and Apoptosis by Targeting Beclin1 Involved in Contrast-induced Acute Kidney Injury, Current Medicinal Chemistry 2021; 28 (38) . https://dx.doi.org/10.2174/0929867328666210526125023
DOI https://dx.doi.org/10.2174/0929867328666210526125023 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
Recent Patents on Anti-Cancer Drug Discovery GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Current Clinical Pharmacology Neonatal Environment and Neuroendocrine Programming of the Peripheral Respiratory Control System
Current Pediatric Reviews Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens
Recent Patents on Biotechnology Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery Current Updates in the Medical Management of Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Antioxidative Effects of Rhodiola Genus: Phytochemistry and Pharmacological Mechanisms against the Diseases
Current Topics in Medicinal Chemistry Development and Characterization of Doxorubicin Bearing Vitamin B12 Coupled Sterically Stabilized Liposomes for Tumor Targeting
Current Nanoscience Selective Serotonin Reuptake Inhibitors in Pregnancy
Current Medicinal Chemistry Synthetic and Natural Products as Iron Chelators
Current Topics in Medicinal Chemistry Soft Matter Assemblies as Nanomedicine Platforms for Cancer Chemotherapy: A Journey from Market Products Towards Novel Approaches
Current Topics in Medicinal Chemistry Vitamin D and Cardiovascular Disease
Current Vascular Pharmacology Drug Withdrawals in the United States: A Systematic Review of the Evidence and Analysis of Trends
Current Drug Safety Systematic Investigation of Quercetin for Treating Cardiovascular Disease Based on Network Pharmacology
Combinatorial Chemistry & High Throughput Screening TRPV1 Function in Health and Disease
Current Pharmaceutical Biotechnology Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design Complex Inheritance for Susceptibility to Sudden Cardiac Death
Current Pharmaceutical Design An Update on Disease Modifying Antirheumatic Drugs
Inflammation & Allergy - Drug Targets (Discontinued) Translational Imaging of Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Brain Angiotensin and Cardiovascular Reactivity to Negative and Positive Emotional Stress
Current Hypertension Reviews